Shenzhen Beike Biotechnology Co., Ltd. announced the successful treatment of two similar spinal cord injury patients using two different procedures that involved umbilical cord stem cells. One method involved surgical transplantation of stem cells directly into the spinal cord, while the other patient received the stem cells without surgery. The announcement was made following a two month rehabilitation and evaluation period by physicians in the patients' native countries of the U.S.A. and Romania. Details can be found on the news website, http://www.stemcellschina.com. Treatments with umbilical cord blood stem cells have been performed for years for patients with leukemia and other...